Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for treatment of angiogenesis-associated ocular disorders

Compositions and methods for treatment of angiogenesis-associated ocular disorders

US Patent 8722015 · Granted May 13, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mouse comprising a humanized TRKB locus2025
Materials and methods of treating MHC-I-opathy risk haplotypes2025
Treatment of uveitis with endoplasmic reticulum aminopeptidase 1 (ERAP1) inhibit2024
Non-human animals models of retinoschisis2024
Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (ANGPTL7)2024
Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors2023
Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors2023
Device for detecting and/or determining the concentration of an analyte present 2022
Polynucleotides encoding anti-C5 antibodies2022
Methods of treating C5-associated diseases comprising administering anti-C5 anti2022
Nutlin-3a for treatment of proliferative vitreoretinopathy2022
Genetically modified rat comprising a humanized TRKB locus2022